Last reviewed · How we verify
Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease
This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease
Details
| Lead sponsor | Sun Pharma Advanced Research Company Limited |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | Thu Mar 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Parkinson Disease
Interventions
- K0706
- Placebo
Countries
United States